Cite
HARVARD Citation
Vermeire, S. et al. (n.d.). DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1. Journal of Crohn's and colitis. pp. i087-i088. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vermeire, S. et al. (n.d.). DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1. Journal of Crohn's and colitis. pp. i087-i088. [Online].